Headlines

Samsung Biologics poised for growth pending BIOSECURE bill approval in US

The US government’s unveiling of the BIOSECURE bill has created a great deal of discussion and debate in the pharma industry.

What innovations are reshaping the pharma services sector?

We sat down with Jay Ferguson, director at Houlihan Lokey's Healthcare Group, to discuss why he views the pharma services sector as a highly promising investment opportunity. He outlines his prediction that a confluence of tailwinds is set to sustain...

Broken String Biosciences to advance ALS research with Francis Crick Institute

Broken String Biosciences, a genomics company driving cell and gene therapy developing, has entered a research collaboration with the Francis Crick Institute, a biomedical discovery institute dedicated to understanding the biology underlying health and...

GLP-1R agonists clinical trial design must be improved to ease concerns

Glucagon-like peptide-1 (GLP-1) receptor agonists, such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro, have garnered a lot of attention in the pharma industry and beyond.